ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
132 hedge funds and large institutions have $209M invested in Antares Pharma, Inc. in 2019 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+12
Holders Change %
+10%
% of All Funds
2.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
25
Increased
38
Reduced
34
Closed
13
Calls
$1.77M
Puts
$2.26M
Net Calls
-$490K
Net Calls Change
+$367K
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$816K |
| 2 |
BC
2
Broadfin Capital
New York
|
$8.01M |
| 3 |
3
Russell Investments Group
London,
United Kingdom
|
$1.32M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$10.9M |
| 5 |
5
BlackRock
New York
|
$30M |
